Common metabolic drug helps memory in mice

Share this article:
A drug that has until now been prescribed to treat patients with a certain metabolic disorder has been found to improve the memory of laboratory animals with Alzheimer's disease, according to a recent report.

Sodium phenylbutyrate is commonly used to treat patients who experience an alteration in the urea cycle. Researchers discovered that the drug also helped certain proteins, which are responsible for neuron connections, fuse together, resulting in improved learning capacity of lab mice. Researchers at the Center for Applied Medical Research (CIMA) at the University of Navarra are investigating which element of the drug is responsible for the beneficial effects.

Because sodium phenylbutyrate is already available for use, researchers suggest it could potentially be used to treat Alzheimer's and other dementia patients much sooner than other experimental drugs. The report was published in the journal Neuropsychopharmacology.
Share this article:

More in News

Also in the news for Sept. 30, 2014 . . .

CMS clarifies appropriate use of power strips in long-term care resident rooms ...GAO: Integrating Medicare and Medicaid may not reduce costs on dual-eligible care ... Brookdale discriminated against worker with fibromyalgia, EEOC claims ... State standards for physician access under Medicaid managed care vary widely, ...

More programs drop out of Pioneer ACO pilot

The Pioneer Accountable Care Organization program is now down to 19 programs, out of an original 32, worrying those who have pushed for skilled nursing facilities to embrace the concept.

Elderly with complicated grief benefit from targeted program, study says

Complicated grief is an under-recognized problem in the elderly, but a specific treatment can help, a new study says.